All Stories

FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout

The new FDA approval gives Daiichi Sankyo’s Turalio some company in a rare tumor type.

Feb 15, 2025 - 00:33
 0
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
The new FDA approval gives Daiichi Sankyo’s Turalio some company in a rare tumor type.
Read More

Tags:

Previous Article

[Correspondence] The urgent need to protect WHO is also an opportunity

Next Article

Massive Law Firm Gets Caught Hallucinating Cases

Related Posts

Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma

Bain throws down $3.3B to acquire Japan's Mitsubishi Ta...

Feb 9, 2025  0

With new FDA approval, GSK joins Pfizer in the 5-in-1 meningococcal vaccine ring

With new FDA approval, GSK joins Pfizer in the 5-in-1 m...

Feb 15, 2025  0

Regulatory tracker: Novartis, Valneva pick up new UK approvals

Regulatory tracker: Novartis, Valneva pick up new UK ap...

Feb 9, 2025  0